A Post-Market Study to Evaluate Adverse Event Incidence Rates in Patients With Skin of Color Undergoing Correction of Nasolabial Folds With Hylaform, Hylaform Plus and Captique.
Clinical trial NCT00293163 · COMPLETED
Trial details
- NCT number
- NCT00293163
- Sponsor
- Genzyme, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2006-02-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.